Eyedeal
Latest round
- Series B
Last raised
- Apr 2023
Total raised
- $15M
Investors
- 3
About Eyedeal
Established in 2015 and based in Xi'an, China, Eyedeal is a research and development manufacturer of ophthalmic medical devices. In 2015, Mr. Guangxu Guo, the founder of the company, purchased the material invention patent of Dr. Len Pinchuk, a member of the National Academy of Engineering, and founded the company. The CTO, Zhou Yang, worked at Alcon. The company has established scientific research platforms such as Shaanxi Provincial Engineering Technology Research Center and Postdoctoral Innovation Base. In 2021, Eyedeal's IOL received CE marketing license in EU. The company mainly produces medical equipment products such as IOLs for the treatment of eye diseases, including IOLs, keratoplasty lenses, crystalline eye IOLs, glaucoma shadow flow tubes and polymer medical materials. Among them, the company has developed a unique cross-linked polyolefin IOL, which was approved as a key project of the National Key Research and Development Program, and the hydrophobic acrylate aspheric IOL was approved for marketing by the State Drug Administration.
Who invested in Eyedeal
3 investors across 1 round
See all investors in Eyedeal
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Apr 23, 2023
Amount
$15M
Investors
Questions about Eyedeal
Who invested in Eyedeal?
Eyedeal has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Eyedeal raised?
Eyedeal has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Eyedeal last raise money?
Eyedeal's most recent round on record is a Series B, in Apr 2023.
What does Eyedeal do?
Established in 2015 and based in Xi'an, China, Eyedeal is a research and development manufacturer of ophthalmic medical devices.
Where is Eyedeal headquartered?
Eyedeal is headquartered in Xi'an, China.
Which VCs invest in companies like Eyedeal?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back medical devices & equipment companies at Eyedeal's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Eyedeal? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.